Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Edge

Showing results (141-150 of 195) with videos related to

Pageof 20
Sort By:
Breast Cancer Research and Treatment|October 27, 2012
Time to diagnosis and breast cancer stage by race/ethnicityErica T Warner, Rulla M Tamimi, Melissa E Hughes, et al.
Cancer|April 19, 2016
Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancerLia M Halasz, Hajime Uno, Melissa Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment FactorsErica T Warner, Rulla M Tamimi, Melissa E Hughes, et al.
Cancer|June 8, 2012
Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situNils D Arvold, Rinaa S Punglia, Melissa E Hughes, et al.
Cancer Causes & Control : CCC|April 26, 2011
Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtypeTheodore M Brasky, Matthew R Bonner, Kirsten B Moysich, et al.
Plos One|July 5, 2012
NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancerFoluso O Ademuyiwa, Wiam Bshara, Kristopher Attwood, et al.
Plos One|March 10, 2011
Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series studySong Yao, Lara E Sucheston, Amy E Millen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional studyInes Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2008
Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer riskSylvia K Quick, Peter G Shields, Jing Nie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2023
Novel Prognostic Staging System for Patients With De Novo Metastatic Breast CancerJennifer K Plichta, Samantha M Thomas, Daniel F Hayes, et al.
Pageof 20

Showing results (141-150 of 195) with videos related to

Sort By:
Pageof 20
Breast Cancer Research and Treatment|October 27, 2012
Time to diagnosis and breast cancer stage by race/ethnicityErica T Warner, Rulla M Tamimi, Melissa E Hughes, et al.
Cancer|April 19, 2016
Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancerLia M Halasz, Hajime Uno, Melissa Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment FactorsErica T Warner, Rulla M Tamimi, Melissa E Hughes, et al.
Cancer|June 8, 2012
Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situNils D Arvold, Rinaa S Punglia, Melissa E Hughes, et al.
Cancer Causes & Control : CCC|April 26, 2011
Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtypeTheodore M Brasky, Matthew R Bonner, Kirsten B Moysich, et al.
Plos One|July 5, 2012
NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancerFoluso O Ademuyiwa, Wiam Bshara, Kristopher Attwood, et al.
Plos One|March 10, 2011
Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series studySong Yao, Lara E Sucheston, Amy E Millen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional studyInes Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2008
Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer riskSylvia K Quick, Peter G Shields, Jing Nie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2023
Novel Prognostic Staging System for Patients With De Novo Metastatic Breast CancerJennifer K Plichta, Samantha M Thomas, Daniel F Hayes, et al.
Pageof 20